✦ LIBER ✦

Interferon-αn1, treatment benefits most patients with chronic myeloid leukaemia

✍ Scribed by N.C. Allan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α for the treatment of elderl

✍ Wolfgang Hilbe; Ute Apfelbeck; Michael Fridrik; Marianne Bernhart; Herwig Niessn 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 79 KB

ANTI-INTERFERON ANTIBODIES IN ALPHA INTE

✍ R. Aitchison; P. Allen; S. Schey; A. C. Newland 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

Thrombotic microangiopathy associated wi

✍ KRESIMIR GALESIC; BORKA BOZIC; IVANA RACIC; MIRA SCUKANEC-SPOLJAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Cost effectiveness of imatinib compared

✍ K. Dalziel; A. Round; R. Garside; K. Stein 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 171 KB

Survival of patients with chronic-phase

✍ David Marin; Sarah Marktel; Richard Szydlo; John P Klein; Marco Bua; Nicola Foot 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 126 KB

Renal Thrombotic Microangiopathy Associa

✍ Colm C. Magee; Kottarathil Abraham; John Farrell; Tony Dorman; Joseph J. Walshe 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 331 KB